Shares News

HENSOLDT (HAG) is a German defence electronics company; its shares have pulled back after FY2025 results showed €4.71bn order intake, €2,455m revenue and €89m net income, alongside 2026 guidance of €2,750m revenue and 18.5%–19% EBITDA margin.

Rheinmetall (RHM) is a German defence group; in Feb 2026 it guided to €15–€16bn group revenue and up to €80bn orders, as Germany’s debt-brake debate and a €500bn fund remained in focus. Past performance is not a reliable indicator of future results. Explore third-party RHM price targets.

Siemens Energy is a German power and grid equipment company; on 3 March 2026 it announced a €2bn share buyback and raised mid-term targets after a capital markets day. Explore third-party ENR price targets and technical analysis. Past performance is not a reliable indicator of future results.

Technicals weaken in the shorter-term time frame, while in sentiment CoT speculators are finally net short all four U.S. equity indices.

Deutsche Telekom (DTE) is a European telecoms group; its 2025 results – revenue €119.08bn – and a Starlink satellite-to-mobile partnership announced in March 2026 remain key reference points. Past performance is not a reliable indicator of future results. Explore third-party DTE price targets.

SAP SE is a German enterprise software group; shares fell 14–16% on 29 Jan 2026 after Q4 2025 cloud backlog rose 25% (cc), below ~26% expectations. Explore third-party SAP price targets and technical analysis. Past performance is not a reliable indicator of future results.

DroneShield (ASX: DRO) develops counter-drone systems and reported FY2025 revenue of $216.5m (+276% YoY), plus $104m secured FY2026 revenue and $21.7m in new contracts. Explore third-party DRO price targets and technical analysis. Past performance is not a reliable indicator of future results.

Thyssenkrupp AG is a German industrial group; it has flagged a €400m–€800m FY2025/26 net loss linked to Steel Europe restructuring and is reviewing options for its Materials Services unit. Past performance is not a reliable indicator of future results. Explore third-party TKA price targets.

Novo Nordisk (NVO) trades near recent lows after February 2026 guidance for -5% to -13% sales growth; FDA warning letters on 3 March briefly supported shares. Past performance is not a reliable indicator of future results. Explore third-party NVO price targets and technical analysis.

Palantir (PLTR) develops data analytics and AI software; Q4 FY2025 revenue rose 70% to $1.41bn and it guided 2026 revenue at about $7.19bn, above consensus. Explore third-party PLTR price targets and technical analysis. Past performance is not a reliable indicator of future results.